Most recently, it's been recognized that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar parts as classical opioid receptors, it binds to your big range of endogenous opioids. Not like most opioid receptors, this receptor acts like a scavenger https://michaelh219oit7.wikitron.com/user